Various lysates were subjected to SDS PAGE followed by western blot with 10084-2-AP (CD71 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours.

Immunohistochemical analysis of paraffin-embedded human placenta tissue slide using 10084-2-AP (CD71 antibody) at dilution of 1:1000 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

Immunohistochemical analysis of paraffin-embedded human placenta tissue slide using 10084-2-AP (CD71 antibody) at dilution of 1:1000 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

IP result of anti-CD71 (IP:10084-2-AP, 4ug; Detection:10084-2-AP 1:500) with HeLa cells lysate 2400ug.

Immunofluorescent analysis of (-20°C Methanol) fixed HeLa cells using CD71 antibody (10084-2-AP) at dilution of 1:200 and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L).

Untreated and PNGase F-treated lysates of Raji cells and HeLa cells were subjected to SDS PAGE followed by western blot with 66180-1-Ig (CD71 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours. PNGase F was obtained from Atagenix (cat.NO. ata808).

Various lysates were subjected to SDS PAGE followed by western blot with 66180-1-Ig (CD71 antibody) at dilution of 1:20000 incubated at room temperature for 1.5 hours. The membrane was stripped and reblotted with HRP-conjugated Beta Actin Monoclonal antibody (HRP-66009) as loading control.

1X10^6 Raji cells were stained with 0.2ug CD71 antibody (66180-1-Ig, red) and control antibody (blue). Fixed with 4% PFA blocked with 3% BSA (30 min). FITC-Goat anti-mouse IgG with dilution 1:100.

Immunohistochemical analysis of paraffin-embedded human placenta tissue slide using 66180-1-Ig (CD71 antibody) at dilution of 1:4000 (under 10x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

Immunohistochemical analysis of paraffin-embedded human placenta tissue slide using 66180-1-Ig (CD71 antibody) at dilution of 1:4000 (under 40x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

Immunofluorescent analysis of (4% PFA) fixed human breast cancer tissue using CD71 antibody (66180-1-Ig, Clone: 3C11F11 ) at dilution of 1:400 and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L).

IP result of anti-CD71 (IP:66180-1-Ig, 5ug; Detection:66180-1-Ig 1:1000) with HeLa cells lysate 2400ug.

Various lysates were subjected to SDS PAGE followed by western blot with 81793-2-RR (CD71 antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

1x10^6 MCF-7 cells were surface stained with 0.25 ug CD71 Recombinant antibody (81793-2-RR, Clone:2P14) and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) (SA00013-2)(red), or 0.25 ug Isotype Control (blue). Cells were not fixed.

G66180-1-5C was used to stain Resting PBMC and analyzed with 10x Genomics Gene Expression Flex with Feature Barcodes and Multiplexing kit with Fix-Stain protocol.

G66180-1-5C was used to stain PBMC under 4hr LPS + TI treatment and analyzed with 10x Genomics Gene Expression Flex with Feature Barcodes and Multiplexing kit with Fix-Stain protocol.

1X10^6 day 3 PHA treated human PBMCs were surface stained with 0.2 ug Anti-Human CD71 (65235-1-Ig, Clone:OKT9) and CL594-Goat anti-Mouse IgG at dilution 1:1000. Cells were not fixed. Lymphocytes were gated. Blue line indicates unstained stimulated cells. Black dashed line indicates unstimulated stained cells.

1x10^6 PHA treated human PBMCs were surface stained with 0.25 ug Anti-Human CD71 Mouse IgG2a Recombinant Antibody (65605-1-MR, Clone: OKT9) (red) or Mouse IgG2a Isotype Control (65208-1-Ig, Clone: C1.18.4) (blue) and CoraLite®488-Conjugated AffiniPure Donkey Anti-Mouse IgG(H+L). Untreated human PBMCs were surface stained with 0.25 ug Anti-Human CD71 Mouse IgG2a Recombinant Antibody (65605-1-MR, Clone: OKT9) and CoraLite®488-Conjugated AffiniPure Donkey Anti-Mouse IgG(H+L) (black). Cells were not fixed.

1x10^6 PHA treated human PBMCs were surface stained with 0.05 ug Anti-Human CD71 Rabbit Recombinant Antibody (65507-1-RR, Clone:OKT9) or Rabbit IgG control Rabbit PolyAb and CoraLite®647-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at dilution 1:1000. Cells were then stained with CL488 Anti-Human CD3. Cells were not fixed. Lymphocytes were gated.

1x10^6 PHA treated human PBMCs were surface stained with 0.05 ug Anti-Human CD71 Rabbit Recombinant Antibody (65507-1-RR, Clone:OKT9) (red) or Rabbit IgG control Rabbit PolyAb (blue); or 1x10^6 untreated human PBMCs were surface stained with 0.05 ug Anti-Human CD71 Rabbit Recombinant Antibody (65507-1-RR, Clone:OKT9) (black dashed). Cells were then stained with CoraLite®647-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at dilution 1:1000. Cells were not fixed. Lymphocytes were gated.

1x10^6 PHA treated human PBMCs were surface stained with 0.05 ug Anti-Human CD71 Rabbit Recombinant Antibody (65507-1-PBS, Clone:OKT9) or Rabbit IgG control Rabbit PolyAb and CoraLite®647-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at dilution 1:1000. Cells were then stained with CL488 Anti-Human CD3. Cells were not fixed. Lymphocytes were gated.

1x10^6 PHA treated human PBMCs were surface stained with 0.05 ug Anti-Human CD71 Rabbit Recombinant Antibody (65507-1-PBS, Clone:OKT9) (red) or Rabbit IgG control Rabbit PolyAb (blue); or 1x10^6 untreated human PBMCs were surface stained with 0.05 ug Anti-Human CD71 Rabbit Recombinant Antibody (65507-1-PBS, Clone:OKT9) (black dashed). Cells were then stained with CoraLite®647-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at dilution 1:1000. Cells were not fixed. Lymphocytes were gated.

1X10^6 C57BL/6 mouse bone marrow cells were surface co-stained with APC Anti-Mouse TER-119 (TER-119) and 0.5 ug Anti-Mouse CD71 (65289-1-Ig, Clone: RI7217) or 0.5 ug Rat IgG2a Isotype Control (2A3), and FITC anti-Rat IgG2a Antibody at dilution 1:100. Cells were not fixed.